- Home
- AARD vs HITI Comparison
AARD vs HITI Comparison
Compare AARD & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- HITI
- Stock Information
- Founded
- AARD 2017
- HITI 2009
- Country
- AARD United States
- HITI Canada
- Employees
- AARD N/A
- HITI N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- HITI
- Sector
- AARD Health Care
- HITI
- Exchange
- AARD Nasdaq
- HITI Nasdaq
- Market Cap
- AARD 186.3M
- HITI 178.6M
- IPO Year
- AARD 2025
- HITI N/A
- Fundamental
- Price
- AARD $16.08
- HITI $3.57
- Analyst Decision
- AARD Strong Buy
- HITI Strong Buy
- Analyst Count
- AARD 7
- HITI 2
- Target Price
- AARD $31.43
- HITI $6.13
- AVG Volume (30 Days)
- AARD 238.4K
- HITI 1.1M
- Earning Date
- AARD 11-14-2025
- HITI 09-15-2025
- Dividend Yield
- AARD N/A
- HITI N/A
- EPS Growth
- AARD N/A
- HITI N/A
- EPS
- AARD N/A
- HITI N/A
- Revenue
- AARD N/A
- HITI $410,600,094.00
- Revenue This Year
- AARD N/A
- HITI $12.28
- Revenue Next Year
- AARD N/A
- HITI $21.83
- P/E Ratio
- AARD N/A
- HITI N/A
- Revenue Growth
- AARD N/A
- HITI 11.18
- 52 Week Low
- AARD $4.88
- HITI $1.64
- 52 Week High
- AARD $19.58
- HITI $4.06
- Technical
- Relative Strength Index (RSI)
- AARD 79.19
- HITI 52.71
- Support Level
- AARD $10.75
- HITI $3.50
- Resistance Level
- AARD $14.32
- HITI $3.89
- Average True Range (ATR)
- AARD 1.07
- HITI 0.24
- MACD
- AARD 0.58
- HITI -0.05
- Stochastic Oscillator
- AARD 95.99
- HITI 19.17
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.